Sunesis: Q1 Earnings Snapshot

·1 min read

CARDIFF, Calif. (AP) _ Viracta Therapeutics, Inc. (VIRX) on Wednesday reported a loss of $79.2 million in its first quarter.

On a per-share basis, the Cardiff, California-based company said it had a loss of $5.22. Earnings, adjusted for non-recurring costs, were 38 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.

Sunesis shares have risen 73% since the beginning of the year. The stock has fallen 42% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VIRX at

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting